LEOSS

Wir suchen Verstärkung in der Forschung, PostDoc, gern mit virolog. Vorerfahrung, Bewerbungen bis 02.01.22, weitere Infos hier: kgu.de/karriere

unsere ersten Daten zur Neutralisation von Omicron versus Delta sind fertig: 2x Biontech, 2x Moderna, 1xAZ/1x Biontech nach 6 Monaten 0% Neutralisation bei Omicron, auch 3x Biontech 3 Monate nach Booster nur 25% NT versus 95% bei Delta. Bis zu 37fache Reduktion Delta vs. Omicron

Auch wichtig- die Antigentests (3 verschiedene von Roche, Siemens und Flowflex) sind auch bei Omicron positiv und funktionieren!

Corona-Lage am 29.10.2020 (links): ⏺️ Wildtypus ⏺️ 0% Impfquote ⏺️ Inzidenz = 99 ⏺️ 1696 Intensivpatienten ⏺️ 367 Tote in 7 Tagen Corona-Lage am 29.10.2021 (rechts): ⏺️ Delta ⏺️ 69% Impfquote ⏺️ Inzidenz = 139 ⏺️ 1868 Intensivpatienten ⏺️ 585 Tote in 7 Tagen @welt

As a European🌍 and international🗺️ network of multidisciplinary teams collaborating on scientific research 🧪🧬🧮of COVID-19, ORCHESTRA aims to work together for a broader understanding of the disease. Interested? Please check out our collaborations site: orchestra-cohort.eu/collaborations/

@mfkuepp I usually agree that the recently hyped PK/PD discussion is in desperate need of meaningful evidence and not matching my clinical experience. But in this case, I'm with Axel: for Enterobacter spp., the resistance mec is well established and breakthroughs frequently reported.

Stanislas Werfel's group designed the CAPS-D score for #COVID19 with @LEOSS_CoV_2 data and is particularly exciting: simple to calculate, good #prediction, and relies only on cheap and universally available clinical parameters. Check out the preprint! medrxiv.org/content/10.110…

@SZ Deutsche Unikliniken nehmen an >200 Studien zu #COVID19 teil drks.de, bieten fast allen Patient*innen eine Studienteilnahme an. Die 1seitige Darstellung ist eine Gemeinheit für die vielen Studienteams, die für uns alle ihre Freizeit opfern und Gesundheit riskieren

Patienten aus Ländern von Ägypten über Iran bis Honduras nahmen an der Solidarity-Studie zu Covid-19-Therapien teil - aber es beteiligte sich keine einzige deutsche Klinik. sz.de/1.5143902?utm_…

Open data comes at a cost - hundreds of hours of analysis for the perfect anonymization algorithms. The result: unbiased results in a deidentified dataset open for public use here rdcu.be/cbX3g. Worth every minute. Thanks to @ArxDev for a great job & tireless effort!

LEOSS just included patient no. 5,000. We are humbled by the continued activity of our study centers in these difficult times. Remember, LEOSS is a community study that does not pay a dime. Our investigators sacrifice their spare time to improve our understanding of #COVIDー19.

First report of the LEOSS cancer cohort is online! Check it out here: link.springer.com/article/10.100… #COVID19 #Cancer

We are very proud of what the DZIF has acchieved in 2019. Read more in our Annual Report: ow.ly/WKQG50Cb2Gt #DZIF_annualreport #infectionreserach #translationalresearch

Well done @rki_de, every German plz grab a copy. Make @LEOSS_CoV_2 obsolete!

We are hiring, PostDoc + PhD in translational cancer outcomes, and you'd be part of the great team that brought you #LEOSS 😏 @DKTK_ @DKFZ

@CiesekSandra bit simple though. all diseases at fixed rates (rates from previous years?), only COVID-19 has an actual dynamic.

Beeindruckende Animation zu COVID19 Todesfällen: Global Deaths Due to Various Causes and COVID-19 | Flourish public.flourish.studio/visualisation/…

Unser erster #FD_Tipp ist europäisch: leoss.net/data/ @LEOSS_CoV_2 #lifesciences

Our newsletter #COVID19 is out! bit.ly/2X6pbVg Topics: interview with Thomas Illig @MHHPublicHealth and Janne Vehreschild about @LEOSS_CoV_2 study, GBN webinar recordings, #DeCOI initiative and much more! Subscribe here: bit.ly/2ZcNyTI #biobank #biobanking

Morgen 14 Uhr im @hih2025 : Premiere: Der ‚Bundeseinheitliche Forschungsdatensatz zu COVID-19‘ Konsens aller Universitätskliniken auf Basis internationaler Standards👏🏻 @LEOSS_CoV_2 @hl7germany @SnomedCT @LOINC @HiGHmed_MI @MIRACUM_de #SMITH #DIFUTURE @sitigde #GECCO 🌍

Remember how we reported that Monday was our day with highest documentation activity yet? Well, that was almost doubled on Tuesday. Incredible. #COVID19

To all the #DataScientists: we are very sorry for the delay, #anonymization pipeline is behind schedule. We know you are waiting and this remains among our top priorities. Publishing data is a high risk for patient #privacy and we must do this 100% on the first try. #COVID19